Plain-English translation of NCT07112235 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that deliberately infects participants with rhinovirus—a common cold virus—in a safe, controlled hospital environment. Researchers want to understand exactly what happens inside the lungs of people with COPD (a chronic lung disease) when they catch a cold, compared to people without lung disease. By studying these biological processes in detail using advanced laboratory techniques, the goal is to discover new medicines and treatments that could prevent or reduce the severity of these flare-ups.
COPD flare-ups triggered by viral infections are a major cause of suffering, death, and healthcare costs worldwide. Currently, doctors don't fully understand the biological mechanisms that cause these dangerous episodes, which makes it hard to develop new treatments. This study uses a controlled cold virus infection model to finally map out these mechanisms in ways that haven't been possible before.
You likely qualify if…
You likely don't qualify if…
Participants will visit the research center where they will be carefully monitored and intentionally exposed to rhinovirus (a mild cold virus). Researchers will then collect samples from the lungs and respiratory tract at multiple time points—both before and after infection—using safe, routine procedures. These samples will be analyzed using advanced techniques to understand the biological changes happening during a flare-up. The study is designed so that repeated sampling can be done safely and easily in this controlled research setting.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United Kingdom